Skip to content

XLVState Street Health Care Select Sector SPDR ETF

Grow my money27y track recordRanked #18 of 2,960 in this goal

Seeks to provide investment results that correspond to the price and yield performance of publicly traded equity securities in the Index.

By State Street Investment Management · Launched 1998

Annual Cost

0.08%

#408 of 5,562 · low cost

Fund Size

$38.2B

#90 of 5,562 · large

Return (1Y)Goal

+13.9%

Track Record

27 years

#56 of 5,562 · established

Performance

Total-return NAV · USD
Growth of $10,000
$11,470+14.7%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Cap

Large

Strategy

Index tracking

Index tracked

Health Care Select Sector Index

What it actually holds

By weight

Concentration

Top 10 holdings = 58.4% of fundmoderately concentrated

Eli Lilly & Co
15.2%
Johnson & Johnson
8.9%
AbbVie Inc
7.2%
UnitedHealth Group Inc
5.3%
Merck & Co Inc
4.7%
Abbott Laboratories
3.9%
Thermo Fisher Scientific Inc
3.9%
Intuitive Surgical Inc
3.6%
Amgen Inc
3.1%
Gilead Sciences Inc
2.7%

Asset allocation

Stocks
99.9%
Cash
0.1%

By sector

Healthcare
100.0%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
15.0%Moderate

Year-on-year price swings

Max drawdown
-28.4%Moderate

Worst peak-to-trough loss

Sharpe (3Y)
0.24Below average
Sortino (3Y)
0.33Moderate downside risk

Where to buy

Listing

Exchange
NYSE Arca

Full fund details

Objective
Seeks to provide investment results that correspond to the price and yield performance of publicly traded equity securities in the Index.
Strategy
Invests primarily in publicly traded equity securities of companies in the Health Care Select Sector. Aims to track the performance of the Health Care Select Sector Index.
Inception date
December 16, 1998
Fund family
State Street Investment Management

What's next?

You've reviewed XLV. Save it to your watchlist to track it alongside the other funds you're weighing.

Data updated on 2026-06-19